{
    "nctId": "NCT04586686",
    "briefTitle": "Combining Interventions of Fertility Preservation to Mitigate Fertility Loss After Breast Cancer",
    "officialTitle": "Combining Interventions of Fertility Preservation to Mitigate Fertility Loss After",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer Female",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 41,
    "primaryOutcomeMeasure": "Mature oocyte yield from biopsied versus non-biopsied ovary",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Age \u2265 18 and \u2264 35 years\n* BMI \u2265 18 and \u2264 35 kg/m\u00b2\n* Diagnosis of breast cancer\n* Presence of 2 ovaries\n* Signed informed consent form\n* Medically fit for general anesthesia (ASA score 1-3)\n* Permission of oncology team (with agreement to postpone chemo/radiotherapy for at least 2 weeks)\n* Random start controlled ovarian stimulation\n* AFC minimum (ie antral follicles measuring between 2-9 mm): 8 antral follicles\n\nExclusion Criteria:\n\n* Age \\<18 or \\>35 years\n* BMI \\<18 or \\>35 kg/m\u00b2\n* Difference in AFC between the ovaries of more than 7 antral follicles\n* Diagnosis of PCOS\n* Previous radiotherapy and/or chemotherapy (neo-adjuvant chemotherapy included)\n* Endometriose rAFS 3-4\n* Allergy or reaction to the use of Elonva\u00ae, Puregon\u00ae, Orgalutran\u00ae, Pregnyl\u00ae Gonapeptyl\u00ae, Decapeptyl\u00ae or letrozole in the past",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT"
}